Le Lézard
Classified in: Health, Science and technology
Subject: Event

Last Chance to Register for This 2 Day Drug Development Training: Key to Success from Concept to Commercialization (July 19-20, 2023) - ResearchAndMarkets.com


The "Drug Development: Key to Success from Concept to Commercialization" training has been added to ResearchAndMarkets.com's offering.

Join Top Drug Development Course To Shape Your Career!

The most successful among all courses for drug development, this course covers the most productive areas. It considers the worldwide market for the pharmaceutical industry along with other significant therapeutic areas. It also takes care of the professionals involved in the pharmaceutical industry.

The course includes a wide spectrum of things and objectives that are necessary for everyone who enrolls for the best Drug Development Course. It includes the identification of drug targets and preparation of chemicals used in the making of drugs of various types.

Furthermore, the experts take care of the developments in biologics, toxicity examination, clinic tests and examination, pre-clinical development, pharmacokinetics, and also pharmacovigilance. The process, thus, takes care of everything from the discovery of the drugs to post-marketing strategies. The developers involved in the process then explain all necessary aspects of the process of drug development.

Objectives of Learning

Every participant can learn the following by the end of this course:

Who Should Attend:

Key Topics Covered:

Presenting the overview of drug development products

View on the global pharmaceutical and drug market

Drug discovery

Break

Supervisory submissions

Break

Pre-clinical development

Clinical research

Pharmacokinetics and toxicity Checks

Break 15 mins

Post-endorsement alteration

US and EU Pharmacovigilance significant fundamentals of rule

For more information about this training visit https://www.researchandmarkets.com/r/pvog0r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: